Widespread Gaps in Alzheimer’s Infusion Therapy Adoption Highlight Access Challenges
The introduction of lecanemab, a new infusion therapy for Alzheimer’s disease (AD), has unveiled stark disparities in access and adoption ...
The introduction of lecanemab, a new infusion therapy for Alzheimer’s disease (AD), has unveiled stark disparities in access and adoption ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine